EMA Phasing Out Routine Trials for Flu Vaccine Makers

Drug Industry Daily
A A
Companies producing vaccines in the EU to protect against annual flu strains will not need to conduct pre-approval clinical trials to support vaccine applications beginning with the 2015/2016 flu season.

To View This Article:

Login

Subscribe To Drug Industry Daily